8 completed, 7 unknown, 5 recruiting, 2 not yet recruiting. 14 Not applicable, 3 Phase 1, 2 Phase 2, 2 Phase 3.
Follow PET-MRI: new trials by email Literature Review of PET-MRI trials Research Report on PET-MRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity 68Ga-Galmydar, PET/MRI, 18F-FDG - Lymphoma Cancer, Breast Cancer | Phase 1 | Not yet recruiting | Washington University School of Medicine | 36 | 2026-11-01 | 2026-09-24 |
| Utility of PET-MRI in Surveillance of Paediatric Brain Tumours PET-MRI - Brain Tumor, Pediatric | Not applicable | Recruiting | Sheffield Children's NHS Foundation Trust | 5 | 2024-02-28 | 2026-05-06 |
| Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications PET-MRI - Head and Neck Cancer | Not applicable | Unknown | Sheffield Teaching Hospitals NHS Foundation Trust | 10 | 2024-01-02 | 2024-04-25 |
| [18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma PET-MRI - Primary Central Nervous System Lymphoma | Phase 1 | Completed | Assistance Publique - Hôpitaux de Paris | 10 | 2023-12-18 | 2025-08-22 |
| Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma PET-MRI - Rectal Cancer | Recruiting | Centre Paul Strauss | 50 | 2023-05-19 | 2026-06-17 | |
| PET-MRI Esophagus Feasibility Study PET-MRI - Esophagogastric Cancer | Not applicable | Recruiting | University Health Network, Toronto | 15 | 2023-03-28 | 2026-03-05 |
| Establishing Radiolabelled PSMA as a Target for Glioma Treatment PET-MRI, Brain tumour biopsy - Glioma, Malignant | Not applicable | Not yet recruiting | King's College Hospital NHS Trust | 30 | 2022-08-01 | 2022-06-10 |
| Measurement of Head and Neck Tumor Hypoxia With PET-MRI PET-MRI - Head and Neck Cancer | Not applicable | Recruiting | Turku University Hospital | 30 | 2022-02-08 | 2022-02-18 |
| Cam Type FAI is a Cause of Hip Pain in the Young Adult and a Precursor to OA Low-dose CT Scan, Blood/Urine Collection, Patient Reported Questionnaires - Hip Dysplasia, Femoroacetabular Impingement | Phase 2 | Unknown | Ottawa Hospital Research Institute | 58 | 2021-02-20 | 2024-01-05 |
| Rectal Cancer Response Hybrid Imaging Assessement PET-MRI - Rectal Cancer | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 96 | 2019-11-27 | 2020-02-05 |
| PET Imaging of Giant Cell and Takayasu Arteritis PET-MRI - Giant Cell Arteritis, Takayasu Arteritis | Unknown | University of Cambridge | 27 | 2019-06-25 | 2024-07-22 | |
| Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients Ga-68 labeled PSMA-11, Positron emission tomography-computed tomography (PET/CT), Positron emission tomography-magnetic resonance imaging (PET/MRI) - Prostate Cancer | Phase 3 | Completed | Thomas Hope | 485 | 2018-10-11 | 2021-08-24 |
| Imaging Histone Deacetylase in the Heart 11C-Martinostat, PET-MRI - Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy | Not applicable | Recruiting | Massachusetts General Hospital | 96 | 2018-09-07 | 2025-12-22 |
| PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients Intensity modulated radiotherapy (IMRT), PET-MRI - Squamous Cell Carcinoma, Oropharynx Cancer | Completed | University of Wisconsin, Madison | 24 | 2018-05-03 | 2022-11-21 | |
| 18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability PET-MRI, Optical Coherence Tomography - Myocardial Infarction, Myocardial Ischemia | Completed | Maastricht University Medical Center | 15 | 2018-03-02 | 2020-02-21 | |
| Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study PET-MRI - NSCLC | Not applicable | Terminated | Gustave Roussy, Cancer Campus, Grand Paris | 11 | 2017-11-25 | 2026-08-19 |
| Improving Awakening Prognostication After Non Anoxic Coma Using PET-MRI in Intensive Care Unit PET-MRI - Coma | Not applicable | Completed | Hospices Civils de Lyon | 38 | 2017-02-16 | 2022-03-07 |
| Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications PET-MRI - Cardiac Disease | Not applicable | Terminated | University of California, San Francisco | 2 | 2016-12-01 | 2021-06-16 |
| PET-CT/MRI in the Radiotherapy for Prostate Cancer PET-CT, PET-MRI - Prostate Cancer | Phase 1 / Phase 2 | Unknown | Xuzhou Medical University | 90 | 2016-09-01 | 2016-06-29 |
| Li-Fraumeni Syndrome Imaging Study Whole body STIR MRI, DW-MRI, PET-MRI - Li-Fraumeni Syndrome | Not applicable | Enrolling by invitation | The Hospital for Sick Children | 30 | 2016-06-20 | 2026-04-29 |
Showing 20 of 25. Sign in to see all of them.
Femoracetabular Impingement (2) · Head and Neck Neoplasms (2) · Prostatic Neoplasms (2) · Rectal Neoplasms (2) · Aortic Valve Stenosis (1) · Atherosclerosis (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Squamous Cell (1) · Cardiotoxicity (1) · Cardiovascular Diseases (1) · Coma (1) · Coronary Artery Disease (1) · Coronary Stenosis (1) · Diabetes Mellitus (1)
Maastricht University Medical Center (3) · Assistance Publique - Hôpitaux de Paris (2) · Massachusetts General Hospital (2) · Ottawa Hospital Research Institute (2) · Turku University Hospital (2) · Centre Paul Strauss (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Hospices Civils de Lyon (1) · King's College Hospital NHS Trust (1) · Sheffield Children's NHS Foundation Trust (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · The Hospital for Sick Children (1) · Thomas Hope (1) · University Health Network, Toronto (1) · University of California, San Francisco (1)
United States (6) · France (5) · Canada (4) · United Kingdom (4) · Netherlands (3) · Finland (2)
Andrea Doria, MD (1) · Jason M Tarkin, MBBS PhD (1) · Jochem van der Pol, MD (1) · Jussi Hirvonen, MD, PhD (1) · Karen G Ordovas, MD,MAS (1) · Longzhen Zhang, MD (1) · M. Eline Kooi, PhD (1) · Markku Voutilainen, MD (1) · Michael Gee, MD, PhD (1) · Ola Rominyi, MBChB (1) · Pamela K Woodard, MD (1) · Paul Beaule, MD, FRCSC (1)
PMID 27162131, PMID 32734484, PMID 35446279
P50DE026787 (1), R01HL180913 (1)